Conjugated linoleic acid (CLA), a peroxisome proliferator-activated receptor (PPAR)-γ agonist, reduces inflammation of monocytes and macrophages through regulation of miRNA, and exerts anti-atherosclerosis effect through this mechanism (154). This evidence concerns the gene PPARG and atherosclerosis.